Top experts by indication / Oncology
Most active experts in MDS / MPN
2026 edition, data as of October 26, 2026
545 key opinion leaders in the directory are tagged to MDS / MPN. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 338 of the 545 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 19 trials |
| 2 | Gautam BorthakurThe University of Texas MD Anderson Cancer Center, TX | 16 trials |
| 3 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 16 trials |
| 4 | Srdan VerstovsekTX | 15 trials |
| 5 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 14 trials |
| 6 | John MascarenhasIcahn School of Medicine at Mount Sinai, NY | 14 trials |
| 7 | Ruben MesaAtrium Health Wake Forest Baptist Comprehensive Cancer Center, NC | 12 trials |
| 8 | Courtney DiNardoThe University of Texas MD Anderson Cancer Center, TX | 9 trials |
| 9 | Judith KarpJohns Hopkins University School of Medicine, MD | 9 trials |
| 10 | Ryotaro NakamuraCity of Hope, CA | 9 trials |
| 11 | Olatoyosi OdenikeUniversity of Chicago, IL | 9 trials |
| 12 | Rami KomrokjiMoffitt Cancer Center, FL | 9 trials |
| 13 | Mikkael SekeresSylvester Comprehensive Cancer Center, FL | 9 trials |
| 14 | Tapan KadiaThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 15 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 16 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 17 | Ronald HoffmanNY | 8 trials |
| 18 | Bart ScottFred Hutchinson Cancer Center, WA | 8 trials |
| 19 | Uday PopatThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 20 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 21 | Prithviraj BoseThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 22 | Philip McCarthyRoswell Park Comprehensive Cancer Center, NY | 8 trials |
| 23 | Naval DaverThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 24 | Ayalew TefferiMayo Clinic, MN | 7 trials |
| 25 | Francis GilesTX | 7 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 117 of the 545 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 270,473 citations |
| 2 | Scott SolomonBrigham and Women's Hospital, MA | 187,732 citations |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 144,714 citations |
| 4 | Wei ZhengVanderbilt University Medical Center | 112,991 citations |
| 5 | Thomas WalshCornell University, NY | 105,956 citations |
| 6 | Ayalew TefferiMayo Clinic, MN | 104,476 citations |
| 7 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 8 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 90,546 citations |
| 9 | Martin TallmanNorthwestern University Feinberg School of Medicine, IL | 89,799 citations |
| 10 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 11 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 12 | Richard StoneDana-Farber Cancer Institute, MA | 77,206 citations |
| 13 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 76,789 citations |
| 14 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 71,079 citations |
| 15 | Mario SznolUniversity of Miami Miller School of Medicine, FL | 69,239 citations |
| 16 | Sergio GiraltMemorial Sloan Kettering Cancer Center, NY | 63,367 citations |
| 17 | Francis GilesTX | 60,986 citations |
| 18 | Malcolm BrennerBaylor College of Medicine, TX | 59,020 citations |
| 19 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 20 | Guido MarcucciCity of Hope, CA | 54,499 citations |
| 21 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
| 22 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 50,317 citations |
| 23 | Courtney DiNardoThe University of Texas MD Anderson Cancer Center, TX | 49,719 citations |
| 24 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 48,319 citations |
| 25 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 47,488 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 85 of the 545 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Hans-Peter KiemWA | 31 awards |
| 2 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 3 | Roland WalterFred Hutchinson Cancer Center, WA | 14 awards |
| 4 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 13 awards |
| 5 | Malcolm BrennerBaylor College of Medicine, TX | 12 awards |
| 6 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 7 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 10 awards |
| 8 | Richard JonesJohns Hopkins University School of Medicine, MD | 10 awards |
| 9 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 10 | Steven GoreMD | 8 awards |
| 11 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 12 | Guido MarcucciCity of Hope, CA | 8 awards |
| 13 | Ephraim FuchsJohns Hopkins University School of Medicine, MD | 7 awards |
| 14 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 15 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 16 | Joanne KurtzbergDuke University Medical Center, NC | 7 awards |
| 17 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 6 awards |
| 18 | Saro ArmenianCity of Hope, CA | 6 awards |
| 19 | Claudio AnasettiMoffitt Cancer Center, FL | 6 awards |
| 20 | Marie BleakleySeattle Children's Hospital, WA | 5 awards |
| 21 | Colleen DelaneyWA | 5 awards |
| 22 | John WagnerUniversity of Minnesota, MN | 5 awards |
| 23 | Jean-Pierre IssaPA | 5 awards |
| 24 | Timothy PardeeAtrium Health Wake Forest Baptist, NC | 5 awards |
| 25 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 5 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 57 of the 545 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 859 contributions |
| 2 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 677 contributions |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 654 contributions |
| 4 | Ghayas IssaThe University of Texas MD Anderson Cancer Center, TX | 275 contributions |
| 5 | Richard StoneDana-Farber Cancer Institute, MA | 242 contributions |
| 6 | Guido MarcucciCity of Hope, CA | 240 contributions |
| 7 | Prithviraj BoseThe University of Texas MD Anderson Cancer Center, TX | 223 contributions |
| 8 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 222 contributions |
| 9 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 10 | Gail RobozWeill Cornell Medicine, NY | 208 contributions |
| 11 | Gary SchillerUniversity of California, Los Angeles, CA | 193 contributions |
| 12 | Ravi VijWashington University School of Medicine in St. Louis, MO | 184 contributions |
| 13 | John MascarenhasIcahn School of Medicine at Mount Sinai, NY | 174 contributions |
| 14 | Anthony SteinCity of Hope, CA | 171 contributions |
| 15 | John DipersioWashington University School of Medicine, MO | 171 contributions |
| 16 | Roland WalterFred Hutchinson Cancer Center, WA | 135 contributions |
| 17 | Geoffrey UyWashington University School of Medicine, MO | 130 contributions |
| 18 | Raajit RampalMemorial Sloan Kettering Cancer Center, NY | 129 contributions |
| 19 | Daniel PollyeaUniversity of Colorado School of Medicine, CO | 128 contributions |
| 20 | David MaloneyFred Hutchinson Cancer Center, WA | 127 contributions |
| 21 | Ryotaro NakamuraCity of Hope, CA | 125 contributions |
| 22 | Vinod PullarkatCity of Hope, CA | 112 contributions |
| 23 | Philippe ArmandMayo Clinic, MN | 111 contributions |
| 24 | Selina LugerUniversity of Pennsylvania, PA | 109 contributions |
| 25 | Amandeep SalhotraCity of Hope, CA | 104 contributions |
Emerging
24 of the 545 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Maria AmayaUniversity of Colorado Anschutz, CO |
| Rafael BejarUniversity of California, San Diego, CA |
| Uma BorateThe Ohio State University, OH |
| Timothy FerngNY |
| Antonio FojoColumbia University Irving Medical Center, NY |
| Peter ForsbergCO |
| Phillip GarfinJazz Pharmaceuticals, CA |
| Hamza HassanRoswell Park Comprehensive Cancer Center, NY |
| Douglas HawkinsSeattle Children's Hospital, WA |
| Anthony HunterEmory University, GA |
| Sakshi JasraUniversity of Vermont, VT |
| Orly LeivaIL |
| Yazan MadanatHarold C. Simmons Comprehensive Cancer Center, TX |
| Tomer MarkKaryopharm Therapeutics, CO |
| Aasiya MatinMayo Clinic, MN |
| Christine McMahonUniversity of Colorado Anschutz, CO |
| Azra RazaColumbia University Irving Medical Center, NY |
| Lindsay ReinDuke University, NC |
| Jayastu SenapatiThe University of Texas MD Anderson Cancer Center, TX |
| Lauren ShihUniversity of Washington, WA |
| Ronan SwordsOregon Health & Science University, OR |
| Tsewang TashiHuntsman Cancer Institute, University of Utah, UT |
| Dan VoglUniversity of Pennsylvania, PA |
| Joshua ZeidnerUniversity of North Carolina at Chapel Hill, NC |
How these tables are computed
The cohort is every profile in the directory tagged to MDS / MPN, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every MDS / MPN profile in the directory